← Eichor
Condition: Nonalcoholic Fatty Liver Disease Nafld Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nonalcoholic Fatty Liver Disease Nafld

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Phase N/A · 1 location(s) · Mayo Clinic · NCT04232566Prevalence of NAFLD in T1DM Patients
NA · 1 location(s) · Ziekenhuis Oost-Limburg · NCT06445361Evaluation of Risk of hEpatocellular Carcinoma
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06523179Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Phase 2 · 5 location(s) · Regeneron Pharmaceuticals · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
NA · 1 location(s) · Stanford University · NCT05165706Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT05526144Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Phase 1/Phase 2 · 1 location(s) · Tanta University · NCT07242222Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Non
NA · 3 location(s) · State Key Laboratory of Subhealth Intervention Technology · NCT07083336Quantifying Hepatic Mitochondrial Fluxes in Humans
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05305287The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
Phase N/A · 1 location(s) · King Saud University · NCT05697991Prevention of NAFLD and CVD Through Lifestyle Intervention
NA · 1 location(s) · Pontificia Universidad Catolica de Chile · NCT05618626The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patient
NA · 3 location(s) · University of Nottingham · NCT07093346Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05330923PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04371042a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients Wit
Phase 1 · 5 location(s) · Tasly Biopharmaceuticals Co., Ltd. · NCT07128797Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis
Phase 3 · 1 location(s) · National Taiwan University Hospital · NCT07265297Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
Phase 2 · 1 location(s) · Tanta University · NCT06863376Target of Suv420h1/2 in Hepatocytes
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06332677Intermittent Fasting for NAFLD in Adults
NA · 1 location(s) · Massachusetts General Hospital · NCT04899102Nonalcoholic Steatohepatitis in Chinese Children
Phase N/A · 1 location(s) · Humanity and Health Research Centre · NCT03190538Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas
Phase 2 · 1 location(s) · AB Biotics, SA · NCT07193927Estrogen Administration for the Treatment of NASH in Postmenopausal Women
Phase 3 · 1 location(s) · Massachusetts General Hospital · NCT04833140Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake
NA · 1 location(s) · Cairo University · NCT06596109Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Phase 2 · 24 location(s) · Can-Fite BioPharma · NCT04697810Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Phase 2 · 1 location(s) · Hudson Biotech · NCT07481734Evaluation of Miricorilant on Liver Fat in Patients With MASLD
Phase 1 · 1 location(s) · Corcept Therapeutics · NCT06947304To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status
Phase N/A · 1 location(s) · Tongji Hospital · NCT07149571
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.